CEWELD Ultra Clean III

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice

Supplemental label elements

EUH210 - Safety data sheet available on request.

Other hazards which do not result in classification

This product contains nickel, which is classified as toxic through prolonged inhalation, a skin sensitizer, and a suspected carcinogen. In its current form within this product, nickel does not contribute to the overall hazard classification. While skin contact is generally not hazardous, it should be avoided to prevent potential allergic reactions. Individuals with pacemakers should consult their doctor and the manufacturer of their device before approaching welding or cutting operations. When this product is used in welding, the primary hazards include exposure to welding fumes, heat, radiation and electric shock. Fumes: Prolonged exposure to welding fumes may cause symptoms such as metal fume fever, dizziness, nausea, and irritation of the nose, throat, or eyes. Chronic overexposure may impair pulmonary function. Prolonged inhalation of nickel and chromium compounds above safe exposure limits may cause cancer. Overexposure to manganese and its compounds beyond safe limits can irreversibly damage the central nervous system, including the brain, potentially resulting in symptoms such as slurred speech, lethargy, tremors, muscular weakness, and gait disturbances. This product contains substances that may cause sensitization. Heat: Spatter and molten metal can cause burns and may ignite fires. Radiation: Arc rays can severely damage eyes and skin. Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Not classified Adverse physicochemical, human health and environmental effects To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice.